NEW YORK, NY / ACCESS Newswire / March 19, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., Inc. (NYSE:MRK) between February 3, 2022 and ...

The Fate series is an incredibly popular and beloved anime. From the outside, it's often regarded as one of the more complex series to watch. There are dozens of spinoff series featuring the Fate ...

'Man, I had a dream, I worked at it, and then one day, bam, here we are with a coffee shop.' Golden State Warriors guard Jimmy Butler has a side hustle that started in 2020 and turned into a ...

Officials didn’t say if the boxes held classified documents. When asked what was in them, one official said, “These are President Trump’s things.” By Clarissa-Jan Lim The FBI has returned ...

This week’s Deadline: Legal Newsletter looks at a looming decision from the Supreme Court on Trump's freezing of congressionally approved spending, plus other legal news. By Jordan Rubin Welcome ...

Ukrainian President Volodymyr Zelensky speaks during an interview with Fox News Chief Political Anchor Bret Baier. Photo by Win McNamee/Getty Images Ukrainian President Volodymyr Zelensky, in his ...

Prime Video has new installments of two familiar series coming in March. First up is season three of The Wheel of Time (March 13), an adaptation of Robert Jordan's fantasy books of the same name.

Apple does say the Mac is the best AI PC, and Microsoft is here for it. Starting today, Microsoft’s AI app called Copilot is now available on the Mac App Store. Copilot, which includes OpenAI ...

Reuters FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. Drugmaker Merck, known as MSD outside of the U.S. and Canada, expects to ...

On February 4, Merck released financial results for Q4 2024, which, as in previous quarters, once again beat analysts' expectations. This was driven by a strong performance by its oncology ...

Ivonescimab, the new drug, was found in a trial conducted in China to have bested Keytruda, the blockbuster medication developed by Merck that has raked in more than $130 billion in sales for the ...